2-Arylacetamido-4-phenylamino-5-substituted pyridazinones as formyl peptide receptors agonists.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Bioorganic & Medicinal Chemistry

• Publication date

  2016-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmc.2016.04.019PMID 27134116PMCID PMC5055850
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Further studies on pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as potent and selective human A1 adenosine receptor antagonists.

  2015cited by this paper
• Synthesis of five and six-membered heterocycles bearing an arylpiperazinylalkyl side chain as orally active antinociceptive agents.

  2015cited by this paper
• FPR2/ALXR agonists and the resolution of inflammation.

  2015cited by this paper
• Antagonism of human formyl peptide receptor 1 (FPR1) by chromones and related isoflavones.

  2014cited by this paper
• Development of small molecule non-peptide formyl peptide receptor (FPR) ligands and molecular modeling of their recognition.

  2014cited by this paper
• Neutrophil isolation from nonhuman species.

  2014cited by this paper
• The HIV‐1 gp41 ectodomain is cleaved by matriptase to produce a chemotactic peptide that acts through FPR2

  2014cited by this paper
• Synthesis and Pharmacological Evaluation of New Pyridazin‐Based Thioderivatives as Formyl Peptide Receptor (FPR) Agonists

  2013cited by this paper
• Further studies on 2-arylacetamide pyridazin-3(2H)-ones: design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists.

  2013cited by this paper
• Synthesis, HPLC enantioresolution, and X-ray analysis of a new series of C5-methyl pyridazines as N-formyl peptide receptor (FPR) agonists.

  2013cited by this paper
• 3-(1H-indol-3-yl)-2-[3-(4-nitrophenyl)ureido]propanamide enantiomers with human formyl-peptide receptor agonist activity: molecular modeling of chiral recognition by FPR2.

  2013cited by this paper
• Hp(2-20) peptide of Helicobacter pylori and the innate immune receptors: specific role(s) of the formyl peptide receptors.

  2012cited by this paper
• Molecular docking of 2-(benzimidazol-2-ylthio)-N-phenylacetamide-derived small-molecule agonists of human formyl peptide receptor 1

  2012cited by this paper
• Synthesis, enantioresolution, and activity profile of chiral 6-methyl-2,4-disubstituted pyridazin-3(2H)-ones as potent N-formyl peptide receptor agonists.

  2012cited by this paper
• Role of formyl peptide receptors (FPR) in abnormal inflammation responses involved in neurodegenerative diseases.

  2012cited by this paper
• Genetic ablation of the fpr1 gene confers protection from smoking-induced lung emphysema in mice.

  2012cited by this paper
• Anti-Inflammatory Role of the Murine Formyl-Peptide Receptor 2: Ligand-Specific Effects on Leukocyte Responses and Experimental Inflammation

  2010cited by this paper
• Therapeutic anti-inflammatory potential of formyl-peptide receptor agonists.

  2010cited by this paper
• The Annexin I Sequence Gln9-Ala10-Trp11-Phe12 Is a Core Structure for Interaction with the Formyl Peptide Receptor 1*

  2010cited by this paper
• Are formyl peptide receptors novel targets for therapeutic intervention in ischaemia–reperfusion injury?

  2010cited by this paper
• Human malignant glioma cells expressing functional formylpeptide receptor recruit endothelial progenitor cells for neovascularization.

  2010cited by this paper
• Identification of Novel Small-Molecule Agonists for Human Formyl Peptide Receptors and Pharmacophore Models of Their Recognition

  2010cited by this paper
• International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family

  2009cited by this paper
• Further studies on arylpiperazinyl alkyl pyridazinones: discovery of an exceptionally potent, orally active, antinociceptive agent in thermally induced pain.

  2009cited by this paper
• 6-methyl-2,4-disubstituted pyridazin-3(2H)-ones: a novel class of small-molecule agonists for formyl peptide receptors.

  2009cited by this paper
• Design and synthesis of novel 2-pyridone peptidomimetic falcipain 2/3 inhibitors.

  2008cited by this paper
• High-Throughput Screening for Small-Molecule Activators of Neutrophils: Identification of Novel N-Formyl Peptide Receptor Agonists

  2007cited by this paper
• N6-[(Hetero)aryl/(cyclo)alkyl-carbamoyl-methoxy-phenyl]-(2-chloro)-5′-N-ethylcarboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A2B adenosine receptor

  2007cited by this paper
• 4-Amino-5-vinyl-3(2H)-pyridazinones and analogues as potent antinociceptive agents: Synthesis, SARs, and preliminary studies on the mechanism of action.

  2007cited by this paper
• N(6)-[(hetero)aryl/(cyclo)alkyl-carbamoyl-methoxy-phenyl]-(2-chloro)-5'-N-ethylcarboxamido-adenosines: the first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor.

  2007cited by this paper
• Novel pyrazolopyrimidopyridazinones with potent and selective phosphodiesterase 5 (PDE5) inhibitory activity as potential agents for treatment of erectile dysfunction.

  2006cited by this paper
• Neutrophils and immunity: challenges and opportunities

  2006cited by this paper
• Inflammatory Resolution: new opportunities for drug discovery

  2004cited by this paper
• Stimulus‐dependent specificity for annexin 1 inhibition of the inflammatory nociceptive response: the involvement of the receptor for formylated peptides

  2004cited by this paper
• Receptors for chemotactic formyl peptides as pharmacological targets.

  2002cited by this paper
• Isoxazolo-[3,4-d]-pyridazin-7-(6H)-one as a potential substrate for new aldose reductase inhibitors.

  1999cited by this paper
• Preparation of 4-Amino-3(2H)-pyridazinones by Direct Amination of 3(2H)-Pyridazinones with Hydrazine

  1989cited by this paper

• Development of small-molecule fluorescent probes targeting neutrophils via N-formyl peptide receptors

  2025cites this paper
• Pyridazinone: A privileged scaffold for synthetic and biomedical applications

  2024cites this paper
• Inflammaging and Immunosenescence in the Post‐COVID Era: Small Molecules, Big Challenges

  2024cites this paper
• Optimization of 4‐amino‐pyridazin‐3(2H)‐one as a valid core scaffold for FABP4 inhibitors

  2023cites this paper
• Studies of N-arylation of adamantane-containing amines using Chan-Lam reaction

  2023cites this paper
• Chan–Lam N-Arylation of Adamantane-Containing Amines

  2023cites this paper
• The formyl peptide receptors FPR1 and FPR2 as targets for inflammatory disorders: recent advances in the development of small-molecule agonists.

  2023cites this paper
• Ligand Growing Experiments Suggested 4-amino and 4-ureido pyridazin-3(2H)-one as Novel Scaffold for FABP4 Inhibition

  2022cites this paper
• Pyridazinones and Structurally Related Derivatives with Anti-Inflammatory Activity

  2022cites this paper
• Synthesis, biological evaluation, molecular modeling, and structural analysis of new pyrazole and pyrazolone derivatives as N‐formyl peptide receptors agonists

  2021cites this paper
• Recent advances in the design and development of formyl peptide receptor 2 (FPR2/ALX) agonists as pro-resolving agents with diverse therapeutic potential.

  2021cites this paper
• Developing selective FPR2 agonists can be a potential approach to treat moderate to severe asthma

  2021cites this paper
• Pyridinone Derivatives as Interesting Formyl Peptide Receptor (FPR) Agonists for the Treatment of Rheumatoid Arthritis

  2021cites this paper
• Azolo[d]pyridazinones in medicinal chemistry.

  2020cites this paper
• Illuminating the path to target GPCR structures and functions.

  2020cites this paper
• Novel formyl peptide receptors (FPRs) agonists with pyridinone and pyrimidindione scaffolds that are potentially useful for the treatment of rheumatoid arthritis.

  2020cites this paper
• Repurposing strategies on pyridazinone-based series by pharmacophore- and structure-driven screening

  2020cites this paper
• Exploration of nitrogen heterocycle scaffolds for the development of potent human neutrophil elastase inhibitors.

  2020cites this paper
• Mechanistic Development and Recent Applications of the Chan-Lam Amination.

  2019cites this paper
• Correspondence: Compound 17b and formyl peptide receptor biased agonism in relation to cardioprotective effects in ischaemia-reperfusion injury

  2018cites this paper
• Efficient 1,3,4-Thiadiazole-4,5-dihydropyridazin-3(2H)-ones as Antimicrobial Agents.

  2018cites this paper
• Synthesis of Five‐ and Six‐Membered N‐Phenylacetamido Substituted Heterocycles as Formyl Peptide Receptor Agonists

  2017cites this paper
• Pyridazinone: an attractive lead for anti-inflammatory and analgesic drug discovery.

  2017cites this paper
• The therapeutic journey of pyridazinone.

  2016cites this paper